Home

GREENBELT CORP /NY

CIK 938354 · last filed 2017-01-06

GREENBELT CORP /NY is a corporate insider who has filed 8 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing, for BTX.WS, was dated Jan 6, 2017. The firm reports its address in New York, NY. 34 SEC filings were submitted jointly with Lineage Cell Therapeutics, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

8

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
277 PARK AVE 27TH FL
NEW YORK, NY 10017
Phone
(212) 350-5100
Related Filers
Lineage Cell Therapeutics, Inc. — 34 joint filings, latest 2020-02-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted 10%+ Owner 1,143,346 — — $0 8 2017-01-06

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-01-06 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Other (J) −238,459 $0 EDGAR
2012-07-31 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Gift (G) −2,000 $0 EDGAR
2010-11-03 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Exer (X) +115,520 $231.0K EDGAR
2009-08-24 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Mixed +15,143 $0 EDGAR
2009-04-20 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Other (J) +3,429 $0 EDGAR
2008-11-20 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Other (J) +60,000 $0 EDGAR
2008-04-16 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Other (J) +300,000 $0 EDGAR
2007-05-08 Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted Other (J) +110,000 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.